- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- March 2009
- October 2006
- July 2002
America's Leading Gay News Source
Price of new once-daily AIDS drug draws criticism
(Photo courtesy of Gilead)
SAN FRANCISCO — Gilead’s new once-daily AIDS drug Stribild provides an attractive option for those with HIV who have never started a meds regiment before, but activists say the $33,000 a year price-tag will make it unattainable for most who need it.
“In the long run, the cost to Gilead to actually produce [Stribild] will be a small fraction of its selling price, which means Gilead can show restraint on…pricing and still make an enormous profit,” AIDS Healthcare Foundation president Michael Weinstein told the Huffington Post, after a massive ACT UP San Francisco demonstration at the drug maker’s headquarters over the price.
Activists are putting pressure not just on Gilead, but on lawmakers to intervene and making HIV drugs more affordable for more people.
Tagged with ACT-UP, AIDS Healthcare Foundation, California, Gilead, HIV/AIDS, Michael Weinstein, San Francisco, Stribild
We welcome your thoughtful, respectful comments. Please read our 'Terms of Service' page for more information about community expectations.
Comments from new visitors, flagged users, or those containing questionable language are automatically held for moderation and may not appear immediately.
view print edition
This is horrific! I can't believe the audacity of drug companies – all of which take total advantage of the fact that people desperately need these medications. Shameful!
[Translate]
That is the sad price we pay for drug companies and their desire to profit. Many of them use federal funds to do their research only to turn around and pick the pockets of those that need the drugs most. Each corporate person who pushes the high price on these types of drugs should realize their actions will haunt not only the world but their souls.
[Translate]